Literature DB >> 8895762

High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2.

G Steiner1, P Cairns, T J Polascik, F F Marshall, J I Epstein, D Sidransky, M Schoenberg.   

Abstract

Collecting duct carcinoma (CDC) of the kidney is a rare malignant neoplasm of distal nephron origin. Previous studies of CDC have shown loss of heterozygosity on chromosomal arm 1q in 57% of the cases studied. To better characterize 1q loss in CDC, we performed high-density mapping of the entire long arm of chromosome 1 in 13 CDC tumor samples. We observed complete deletion of chromosomal arm 1q in 5 samples and partial deletion in 4 additional tumors. Our study further showed that the region of minimal deletion is located at 1q32.1-32.2. Sixty-nine percent (9 of 13) of the tumors showed loss of heterozygosity in this area. These data suggest that a gene or group of genes that contribute to the development of distal nephron tumors may be located within the 1q32.1-32.2 region.

Entities:  

Mesh:

Year:  1996        PMID: 8895762

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  SOX13 exhibits a distinct spatial and temporal expression pattern during chondrogenesis, neurogenesis, and limb development.

Authors:  Yi Wang; Sika Ristevski; Vincent R Harley
Journal:  J Histochem Cytochem       Date:  2006-07-11       Impact factor: 2.479

Review 2.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.

Authors:  M-H Wei; O Toure; G M Glenn; M Pithukpakorn; L Neckers; C Stolle; P Choyke; R Grubb; L Middelton; M L Turner; M M Walther; M J Merino; B Zbar; W M Linehan; J R Toro
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

4.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.

Authors:  Jorge R Toro; Michael L Nickerson; Ming-Hui Wei; Michelle B Warren; Gladys M Glenn; Maria L Turner; Laveta Stewart; Paul Duray; Ousman Tourre; Nirmala Sharma; Peter Choyke; Pamela Stratton; Maria Merino; McClellan M Walther; W Marston Linehan; Laura S Schmidt; Berton Zbar
Journal:  Am J Hum Genet       Date:  2003-05-22       Impact factor: 11.025

5.  NORE1A tumor suppressor candidate modulates p21CIP1 via p53.

Authors:  Diego F Calvisi; Howard Donninger; Michele D Vos; Michael J Birrer; Laura Gordon; Virna Leaner; Geoffrey J Clark
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

6.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

Review 7.  The Ras-association domain family (RASSF) members and their role in human tumourigenesis.

Authors:  Louise van der Weyden; David J Adams
Journal:  Biochim Biophys Acta       Date:  2007-07-04

Review 8.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

9.  Bilateral kidneys involvement of collecting duct carcinoma with cystic change: A case report.

Authors:  Guanghui Gong; Ting Lin; Yishu Yuan; Yulai Li; Ruijie Liu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.